We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Zentiva

News List

Zentiva buys Amneal subsidiary Creo Pharmaceuticals pharmaceutical-technology
April 23, 2019
Zentiva buys Amneal subsidiary Creo Pharmaceuticals.
Amneal Divests Creo Pharma contractpharma
April 02, 2019
Zentiva to take over commercial operations in the UK.
Sanofi to sell generics unit for 1.9 billion Euros pharmatimes
July 17, 2018
Global investment group Advent International says it has entered into exclusive negotiations to buy Sanofi’s generics arm Zentiva for 1.9 billion Euros ($2.4 billion).
Sanofi to Sell its Generic Division to Advent for $2.4 Billion biospace
April 18, 2018
Paris-based Sanofi has agreed to sell its generics division, Zentiva, to Advent International.